According to data from MarketBeat, Horizon Therapeutics Public has a consensus rating of “Hold” and an average price target of $110.

Source: https://www.etfdailynews.com/2023/10/18/horizon-therapeutics-public-limited-nasdaqhznp-position-boosted-by-polaris-capital-management-llc/

Amalgamated Bank lowered its holdings in shares of Horizon Therapeutics Public Limited () by 6.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).

Source: https://www.etfdailynews.com/2023/02/21/amalgamated-bank-sells-1626-shares-of-horizon-therapeutics-public-limited-nasdaqhznp/

And Horizon Therapeutics (NASDAQ:) is up more than 4% after the Federal Trade Commission dropped its in-house trial challenging Amgen's (

Source: https://seekingalpha.com/article/4631475-wall-street-breakfast-podcast-xpeng-partners-with-didi-global?source=feed_all_articles

Biotechnology giant Amgen Inc. began talks with investors Tuesday about a potential jumbo bond deal to help finance its roughly $28 billion acquisition of Dublin-based Horizon Therapeutics, according to the company and deal documents.

Source: https://biztoc.com/x/43716f8233e04893?ref=ff

Equities analysts forecast that Horizon Therapeutics Public Limited will post 4.95 EPS for the current year.

Source: https://www.etfdailynews.com/2023/07/08/banque-cantonale-vaudoise-has-40000-stake-in-horizon-therapeutics-public-limited-nasdaqhznp/

Finally, BMO Capital Markets cut shares of Horizon Therapeutics Public from an “outperform” rating to a “market perform” rating in a report on Tuesday, December 13th.

Source: https://www.etfdailynews.com/2023/02/21/amalgamated-bank-sells-1626-shares-of-horizon-therapeutics-public-limited-nasdaqhznp/

Horizon Therapeutics Public Limited has a 12 month low of $57.84 and a 12 month high of $113.83.

Source: https://www.etfdailynews.com/2023/07/13/asset-management-one-co-ltd-grows-stock-position-in-horizon-therapeutics-public-limited-nasdaqhznp/

We've announced the acquisition of Horizon Therapeutics for $27.8 billion.

Source: https://seekingalpha.com/article/4585688-amgen-inc-amgn-presents-43rd-annual-td-cowen-healthcare-conference-transcript?source=feed_all_articles